Back to top
more

BioRad Laboratories (BIO)

(Delayed Data from NYSE)

$276.80 USD

276.80
530,933

-7.80 (-2.74%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $276.78 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (173 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Headquartered in Hercules, CA, Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels in over 35 countries outside the United States through subsidiaries which focus on sales, customer service and product distribution.

Zacks Equity Research

Dull Q1 Earnings & Tough Industry Spell Trouble for BioScrip

by Zacks Equity Research

On May 10, we issued an updated research report on BioScrip, Inc. (BIOS ), a pure-play Infusion Service provider.

    Zacks Equity Research

    Becton (BDX) Announces $4.5B Follow-On Share Offerings

    by Zacks Equity Research

    Becton, Dickinson and Company (BDX), popularly known as BD, recently announced a follow-on offering of $4.5 billion for its shares.

      Zacks Equity Research

      STERIS (STE) Tops Q4 Earnings & Revenues, Issues '18 View

      by Zacks Equity Research

      STERIS Plc (STE) reported fourth-quarter fiscal 2017 adjusted earnings per share (EPS) of $1.11, up 23.3% from the year-ago quarter.

        Tirthankar Chakraborty headshot

        New Strong Buy Stocks for May 9th

        by Tirthankar Chakraborty

        Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

          Zacks Equity Research

          Medical Product Stocks' Earnings Due on May 4: ABMD & More

          by Zacks Equity Research

          Here we discuss four major Medical Product bigwigs, which are scheduled to release their earnings results on May 4.

            Zacks Equity Research

            MedTech Stocks' Earnings Due on Feb 23: TFX, SAUHF, BIO, PDCO

            by Zacks Equity Research

            Let's take a look at the major MedTech stocks slated to release their Oct-Dec 2016 numbers on Feb 23.

              Zacks Equity Research

              New Strong Sell Stocks for February 17th

              by Zacks Equity Research

              Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: